Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Publications
  • Media
  • Contact

Pulmonology/respiratory

Product Candidate

RespiraWell

Blackboard tree bark is recognized for its potential immune-boosting properties, which may fortify the body’s natural defenses during seasonal changes. Kutki root extract, with its antioxidant and anti-inflammatory effects, may assist in reducing inflammation and supporting respiratory health. Swertia chirayita acts as a natural defender. Kuberaksha seeds are known for their anti-inflammatory and antipyretic properties.

The supplement comes in easy-to-consume tablets. For optimal use, adults can take four tablets (500 mg per tablet) thrice daily for 5-7 days during seasonal challenges. Children aged 5-12 years can take two tablets thrice daily for 5-7 days, while children below five years can consume the powder of one tablet three times a day.

RespiraWell is carefully formulated using premium herbal ingredients to ensure safety and efficacy. The supplement is free from harmful additives and preservatives, making it a reliable choice for those seeking natural support during seasonal changes.

As with any supplement, pregnant or nursing women, individuals with underlying medical conditions, or those taking medications are advised to consult a healthcare provider before introducing any new product into their wellness routine.

References

Related research in PubMed (AYUSH 64)

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS